Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

RP Bio Inc. (314140.KQ)

5,500.00
-40.00
(-0.72%)
At close: May 2 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
123,966,689.44
123,966,689.44
151,046,484.34
138,109,319.11
114,963,993.24
Cost of Revenue
116,768,857.82
116,768,857.82
135,477,217.77
120,330,016.39
102,026,178.73
Gross Profit
7,197,831.62
7,197,831.62
15,569,266.57
17,779,302.72
12,937,814.51
Operating Expense
7,891,472
7,891,472
8,946,520
8,132,493
7,057,967
Operating Income
-693,640.38
-693,640.38
6,622,746.57
9,646,809.72
5,879,847.51
Net Non Operating Interest Income Expense
-729,561.39
-729,561.39
-1,091,810.88
-866,960.92
-813,591.91
Pretax Income
-1,217,001.42
-1,217,001.42
5,657,633.83
5,668,714.04
4,290,817.62
Tax Provision
-309,876.85
-309,876.85
220,380.65
1,353,064
478,256.37
Net Income Common Stockholders
-907,124.57
-907,124.57
5,437,253.18
4,315,650.04
3,812,561.25
Basic EPS
-105.00
--
630.00
617.00
580.00
Diluted EPS
-105.00
--
582.00
606.00
580.00
Basic Average Shares
8,639.28
--
8,630.56
6,994.57
6,573.38
Diluted Average Shares
8,639.28
--
9,342.36
7,121.54
6,573.38
Total Operating Income as Reported
-693,640.78
-693,640.78
6,622,747.03
9,646,809.66
5,879,847.32
Rent Expense Supplemental
17,890
17,890
20,979
21,650
17,473
Total Expenses
124,660,329.82
124,660,329.82
144,423,737.77
128,462,509.39
109,084,145.73
Net Income from Continuing & Discontinued Operation
-907,124.57
-907,124.57
5,437,253.18
4,315,650.04
3,812,561.25
Normalized Income
-836,064.08
-836,064.08
5,173,636.97
5,121,258.64
3,781,783.13
Interest Income
521,510
521,510
703,690
316,787
165,625
Interest Expense
1,251,071
1,251,071
1,795,501
1,183,749
979,217
Net Interest Income
-729,561.39
-729,561.39
-1,091,810.88
-866,960.92
-813,591.91
EBIT
34,069.58
34,069.58
7,453,134.83
6,852,463.04
5,270,034.62
EBITDA
6,852,145.58
6,852,145.58
13,501,560.83
12,255,228.04
10,473,488.62
Reconciled Cost of Revenue
116,768,857.82
116,768,857.82
135,477,217.77
120,330,016.39
102,026,178.73
Reconciled Depreciation
6,818,076
6,818,076
6,048,426
5,402,765
5,203,454
Net Income from Continuing Operation Net Minority Interest
-907,124.57
-907,124.57
5,437,253.18
4,315,650.04
3,812,561.25
Total Unusual Items Excluding Goodwill
-95,335
-95,335
274,301
-1,058,187
34,639
Total Unusual Items
-95,335
-95,335
274,301
-1,058,187
34,639
Normalized EBITDA
6,947,480.58
6,947,480.58
13,227,259.83
13,313,415.04
10,438,849.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-24,274.51
-24,274.51
10,684.79
-252,578.40
3,860.88
12/31/2021 - 9/29/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

000640.KS Dong-A Socio Holdings Co., Ltd.
100,100.00
-2.82%
 
4574.T Taiko Pharmaceutical Co.,Ltd.
273.00
-1.44%
 
195940.KQ HK inno.N Corporation
40,150.00
-0.37%
 
000423.SZ Dong-E-E-Jiao Co.,Ltd.
54.41
+0.76%
 
000538.SZ Yunnan Baiyao Group Co.,Ltd
57.27
+1.27%
 
000100.KS Yuhan Corporation
113,500.00
-0.26%
 
BLISSGVS.NS Bliss GVS Pharma Limited
117.93
-0.74%